Jaewon Choi

Jaewon Choi is a seasoned professional in cell therapy process development with extensive experience at BioNTech SE, where responsibilities include leading the engineering team in designing Neo-antigen T cell therapies and managing projects in personalized cell therapy. Choi has a strong background in process improvement and optimization, demonstrated through various roles at Neon Therapeutics, Bristol-Myers Squibb, and Dana-Farber Cancer Institute, focusing on TCR recognition, perfusion model studies, and antibody production. Educational qualifications include a Master of Science in Biology from Yonsei University and a Clinical Research Certificate from Boston College.